Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD.
Wen YangFahim EbrahimiStefano RomeoMagnus HolmerJohan VessbyMattias EkstedtJonas F LudvigssonYing ShangHannes HagströmPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
FDRs of patients with MASLD did not have a higher rate of incident MALO than the general population. Since the absolute risk of MALO in relatives of patients with MASLD was low, these results do not support systematic screening of MASLD-related fibrosis in relatives of patients with MASLD.